RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+4.97%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$2.3B
AUM Growth
+$2.3B
(+13%)
Cap. Flow
+$300M
Cap. Flow
% of AUM
13.06%
Top 10 Holdings %
Top 10 Hldgs %
43.45%
Holding
86
New
20
Increased
27
Reduced
19
Closed
15
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
$68.1M |
| 2 |
Abbott
ABT
|
$51.2M |
| 3 |
BLUE
bluebird bio
BLUE
|
$46.3M |
| 4 |
Teleflex
TFX
|
$35.1M |
| 5 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
$34.9M |
Top Sells
| 1 |
AET
Aetna Inc
AET
|
$37.2M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$36.8M |
| 3 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$34.4M |
| 4 |
Molina Healthcare
MOH
|
$31.7M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$28.7M |
Sector Composition
| 1 | Healthcare | 92.78% |
| 2 | Financials | 1.18% |
| 3 | Communication Services | 0.58% |
| 4 | Technology | 0.01% |
| 5 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARRY
1
DELISTED
Array Biopharma Inc
ARRY
| $245M | 10.64% | 19,113,864 +1,557,278 | +9% | +$19.9M |
|
2
Amicus Therapeutics
FOLD
$2.34B
| $144M | 6.27% | 10,025,770 -986,791 | -9% | -$14.2M |
|
3
Puma Biotechnology
PBYI
$254M
| $90.3M | 3.93% | 913,573 +6,931 | +0.8% | +$685K |
|
|
CLVS
4
DELISTED
Clovis Oncology, Inc.
CLVS
| $89.8M | 3.9% | 1,320,027 +323,417 | +32% | +$22M |
|
5
Wave Life Sciences
WVE
$1.53B
| $77.5M | 3.37% | 2,209,107 -58,600 | -3% | -$2.06M |
|
|
ALDR
6
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $74.5M | 3.24% | 6,505,766 +29,000 | +0.4% | +$332K |
|
7
AstraZeneca
AZN
$248B
| $70.2M | 3.05% | 2,021,600 -224,700 | -10% | -$7.8M |
|
8
Insmed
INSM
$28.8B
| $70.1M | 3.05% | 2,249,262 +257,616 | +13% | +$8.03M |
|
|
IMGN
9
DELISTED
Immunogen Inc
IMGN
| $69.9M | 3.04% | 10,906,962 +2,845,465 | +35% | +$18.2M |
|
|
CELG
10
DELISTED
Celgene Corp
CELG
| $68.1M | 2.96% | +653,000 | New | +$68.1M |
|
|
SGEN
11
DELISTED
Seagen Inc. Common Stock
SGEN
| $61.8M | 2.69% | 1,156,021 -687,712 | -37% | -$36.8M |
|
12
Penumbra
PEN
$10.6B
| $58.1M | 2.53% | 617,279 +51,768 | +9% | +$4.87M |
|
13
Centene
CNC
$14.3B
| $54.6M | 2.37% | 541,500 +136,900 | +34% | +$13.8M |
|
|
14
Abbott
ABT
$231B
| $51.2M | 2.23% | +896,900 | New | +$51.2M |
|
15
Atara Biotherapeutics
ATRA
$84.6M
| $51M | 2.22% | 2,815,988 -73,722 | -3% | -$1.33M |
|
16
LivaNova
LIVN
$3.08B
| $49.2M | 2.14% | 615,588 -16,900 | -3% | -$1.35M |
|
17
Regenxbio
RGNX
$451M
| $47.4M | 2.06% | 1,425,272 -242,400 | -15% | -$8.06M |
|
|
SYNH
18
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $46.5M | 2.02% | 1,067,318 +799,400 | +298% | +$34.9M |
|
|
BLUE
19
DELISTED
bluebird bio
BLUE
| $46.3M | 2.01% | +259,800 | New | +$46.3M |
|
20
iRhythm Technologies
IRTC
$5.46B
| $45.7M | 1.98% | 814,574 +262,533 | +48% | +$14.7M |
|
|
21
Teleflex
TFX
$5.59B
| $42.9M | 1.87% | 172,486 +141,121 | +450% | +$35.1M |
|
|
CTLT
22
DELISTED
CATALENT, INC.
CTLT
| $34.2M | 1.49% | 833,063 +685,400 | +464% | +$28.2M |
|
23
Fate Therapeutics
FATE
$120M
| $33.4M | 1.45% | 5,465,486 +4,046,428 | +285% | +$24.7M |
|
24
UnitedHealth
UNH
$281B
| $32.8M | 1.42% | 148,620 +146,800 | +8,066% | +$32.4M |
|
|
CBIO
25
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
| $32.4M | 1.41% | 1,930,668 +716,580 | +59% | +$12M |
|